Human Insulin Market Size, Trends, Forecast by 2026

1. Global Human Insulin Market Research and Forecast Report 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Human Insulin Market Research Report: According to the latest report by IMARC Group, titled "Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global human insulin market reached a strong growth in 2020. Human insulin (HI) is a short-acting insulin that is synthesized in laboratories. Commonly utilized to mimic the function of natural insulin present in humans, it is bio-engineered by growing insulin proteins within E-coli bacteria (Escherichia coli). It is available as a solution and suspension and is required to be injected subcutaneously. It is widely employed for controlling the blood sugar levels of patients with type I and II diabetes. HI functions by aiding the sugar produced by the human body to move from the blood to other body tissues where it is used for energy. It can additionally stop the liver from producing more sugar. Apart from this, HI also assists in inhibiting the hepatic glucose production and improving the protein synthesis of the body. Request Free Sample Report: https://www.imarcgroup.com/human-insulin-market/requestsample

4. Report Description and Highlights Report Description Global Human Insulin Market Trends : The market is primarily driven by the growing incidences of diabetes and obesity on the global level. This can be attributed to the shifting dietary patterns, sedentary lifestyles led by the masses and the growing geriatric population. In addition to this, the rising awareness regarding the complications of prolonged diabetes, such as cataracts, heart attack and kidney failure, is expected to facilitate the uptake of HI by diabetic patients. Moreover, there has been a gradual shift from standard needles for administering HI to advanced alternatives. The adverse effects of using a traditional needle include infections and bloodborne pathogen transmission. This has compelled healthcare professionals to prescribe pen devices and safety pen needles to administer HI as they cause minimal discomfort. The market is further driven by the increasing preference for biosimilar drugs due to their cost-effectiveness and enhanced efficiency. Furthermore, extensive research and development (R&D) undertaken by key market players has led to the introduction of oral insulin variants. These alternatives are anticipated to offer a safe, effective and convenient method of delivering insulin therapy, which, in turn, will create a positive outlook for the market. Looking forward, the market value is projected to reach a strong growth during the forecast period (2021- 2026).

5. Report Description and Highlights Report Description Market Summary: Breakup by Product Type: •Drugs • Human Insulin Analogs and Biosimilars • Rapid Acting • Long Acting • Premixed • Human Insulin Biologics • Short Acting • Intermediate Acting • Premixed •Delivery Devices • Pens • Reusable Pens • Disposable Pens • Pen Needles • Standard Pen Needles • Safety Pen Needles • Syringes • Others

6. Report Description Report Description and Highlights Breakup by Distribution Channel: •Retail Pharmacies •Hospital Pharmacies •Online Retail Stores •Others Breakup by Disease Type: •Type I Diabetes •Type II Diabetes Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia

7. Report Description Report Description and Highlights • • Indonesia Others •Europe • • • • • • • Germany France United Kingdom Italy Spain Russia Others •Latin America • • • • • • • •Middle East and Africa Turkey •Saudi Arabia Brazil Mexico Argentina Columbia Chile Peru Others

8. Report Description Report Description and Highlights •Iran •United Arab Emirates •Others Note: We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report. Competitive Landscape with Key Players: • B. Braun Melsungen AG • Becton Dickinson & Company • Biocon • Eli Lilly and Company • Julphar • Novo Nordisk • Pfizer • Sanofi • Sedico • Wockhardt • Ypsomed Holding

9. Report Description Report Description and Highlights View Full Report with TOC & List of Figure: https://www.imarcgroup.com/human-insulin-market

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com